Roche MS Drug Ocrevus Gets Marketing Authorization in Europe
Roche’s (RHHBY) multiple sclerosis drug Ocrevus gets approval in Europe thereby boosting its neuroscience portfolio. The drug is already approved in the United States.
Source:: https://finance.yahoo.com/news/roche-ms-drug-ocrevus-gets-115311372.html
